VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $7,900,000 | -17.2% | 551,300 | 0.0% | 0.02% | -21.7% |
Q2 2017 | $9,537,000 | +41.0% | 551,300 | -10.1% | 0.02% | +35.3% |
Q1 2017 | $6,762,000 | -24.1% | 613,100 | -0.1% | 0.02% | -26.1% |
Q4 2016 | $8,912,000 | -4.7% | 613,800 | +61.1% | 0.02% | -4.2% |
Q3 2016 | $9,351,000 | +21.9% | 380,900 | 0.0% | 0.02% | +20.0% |
Q2 2016 | $7,671,000 | -87.5% | 380,900 | -74.7% | 0.02% | -87.2% |
Q1 2016 | $61,433,000 | -63.2% | 1,507,302 | -8.4% | 0.16% | -62.7% |
Q4 2015 | $166,964,000 | -11.8% | 1,644,632 | +55.7% | 0.42% | -12.4% |
Q3 2015 | $189,337,000 | -19.2% | 1,056,387 | +0.1% | 0.48% | -14.7% |
Q2 2015 | $234,442,000 | -1.0% | 1,055,332 | -11.5% | 0.56% | -0.9% |
Q1 2015 | $236,722,000 | +38.8% | 1,191,832 | 0.0% | 0.56% | +36.2% |
Q4 2014 | $170,563,000 | +28.6% | 1,191,832 | +17.9% | 0.41% | +25.8% |
Q3 2014 | $132,617,000 | +2.6% | 1,010,802 | -1.3% | 0.33% | +5.1% |
Q2 2014 | $129,198,000 | +8.6% | 1,024,402 | +13.5% | 0.31% | -0.6% |
Q1 2014 | $118,982,000 | +12.3% | 902,542 | -0.0% | 0.32% | +9.4% |
Q4 2013 | $105,982,000 | +12.5% | 902,742 | 0.0% | 0.29% | +5.1% |
Q3 2013 | $94,183,000 | -7.2% | 902,742 | -23.4% | 0.27% | -11.3% |
Q2 2013 | $101,509,000 | – | 1,179,242 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |